References
| BMG | ##NO_MATCH##.1994) |
| CEFIC | Guidelines for Handling and Distribution of Propylene Glycol USP/Ph.Eur., Propylene Oxide/Propylene Glycols Sector Group of CEFIC (1999) |
| CEFIC/EFPIA | ##NO_MATCH##.1996) |
| DEFIC/FECC | ##NO_MATCH##.1999) |
| EU GL | ##NO_MATCH##.1999) |
| FDA | ##NO_MATCH##.2001) |
| FDA | Code of Federal Regulation title 21 part 11 Electronic Records, Electronic Signatur, Final rule (March 1997) |
| FDA | ##NO_MATCH##.1993) |
| FDA/DHSS | Draft Guidance for Industry on Manufacturing, Processing or Holding APIs (March 1998) |
| FECC/VCH/VDC | ##NO_MATCH##.1998) |
| ICH | Guideline on GMP for APIs (Q7A, July 2001) |
| ICH | ##NO_MATCH##.1999) |
| ICH | ##NO_MATCH##.1999) |
| ICH | ##NO_MATCH##.2000) |
| IPEC | Audit Guide for Distributors of Bulk Pharmaceutical Excipients (April 2000, currently under revision) |
| IPEC | ##NO_MATCH##.2001) |
| ISO 9001 | ##NO_MATCH##.2000) |
| ISPE | Baseline Pharm. Engineer. Guides, Bulk Ph. Chem. (June 1996) |
| PhRMA | ##NO_MATCH##.1995) |
| PIC/S API | ##NO_MATCH##.1987) |
| PIC/S API | ##NO_MATCH##.1997) |
| WHO | GMP for Pharmaceutical Products of the World Health Organization, WHOTechnical Report Series, No. 823, 32nd Report, Geneva (1992) |
| WHO, FDA, CDC | The Diethylene Glycol Contamination Prevention Workshop (Feb. 20-21, 1997), Washington, D.C. |
| WHO | GMP Supplementary Guidelines for the Manufacture of Pharmaceutical Excipients; WHO Technical Report Series, No. 885 (1999) |
